Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3

Published on 19 Nov 2024 on Insider Monkey · via Yahoo Finance

Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In...

Insider Monkey · via Yahoo Finance 17 Dec 2024

It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...

Simply Wall St. · via Yahoo Finance 6 Dec 2024

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...

Insider Monkey · via Yahoo Finance 23 Nov 2024

Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024...

Insider Monkey · via Yahoo Finance 19 Nov 2024

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 19 Nov 2024

HP Investors are enthralled with artificial intelligence. Making printers and selling the ink to ...

GuruFocus.com · via Yahoo Finance 18 Nov 2024

After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment,...

Benzinga · via Yahoo Finance 13 Nov 2024

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarte...

Insider Monkey · via Yahoo Finance 1 Nov 2024

On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of...

Benzinga · via Yahoo Finance 31 Oct 2024

, opens new tab on Thursday reported weaker-than-expected quarterly sales of the higher dose vers...

Reuters 31 Oct 2024